Pooja Ghatalia

机构：Fox Chase Cancer Center, Temple University Health System · ORCID：0000-0001-6229-7581

发表论文 292 篇 · 总被引 3054 次 · h-index 29

代表论文

Circulating tumor DNA (ctDNA) to guide response-adapted bladder preservation in muscle invasive bladder cancer (MIBC): Integrated analysis of the RETAIN trials. (2026 · Journal of Clinical Oncology · 被引 7)
Biomarker analysis from the phase 2 LITESPARK-013 study of 2 different belzutifan (bel) doses in participants (pts) with advanced clear cell renal cell carcinoma (ccRCC). (2026 · Journal of Clinical Oncology · 被引 2)
Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder Cancer (2026 · Clinical Genitourinary Cancer · 被引 1)
Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response (2026 · Clinical Genitourinary Cancer)
IP40-12 RENAL FUNCTION PRESERVATION WITH NEOADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS WITH CHRONIC KIDNEY DISEASE (2026 · The Journal of Urology)
IP08-22 RADIOGRAPHIC RESPONSE TO NEOADJUVANT THERAPY FOR RENAL CELL CARCINOMA DOES NOT CORRELATE TO PATHOLOGIC RESPONSE USING IMMUNE-RELATED RESIDUAL VIABLE TUMOR (IRRVT) (2026 · The Journal of Urology)